Special Topic: Regimen C Updates Please join us on Thursday, January 12 at 5:00 pm EST (4:00 pm CST/2:00 pm PST) for a webinar about the HEALEY ALS Platform Trial. Sabrina Paganoni, MD, PhD, and Merit Cudkowicz, MD, MSc will present updates on the Platform Trial and answer questions from the audience. In addition, we will be […]
Weekly Q&A with guest speaker Jonathan Katz, MD, Site Investigator at CPMC
Today the topline results were announced from the pridopidine regimen of the HEALEY ALS Platform Trial. The HEALEY ALS Platform Trial is designed to accelerate the development of breakthrough treatments for persons with ALS by testing multiple drugs at the same time. Please read the full announcement here We extend our sincere gratitude to […]